Suppr超能文献

相似文献

1
Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporter.
Bioorg Med Chem Lett. 2010 Feb 15;20(4):1330-3. doi: 10.1016/j.bmcl.2010.01.016. Epub 2010 Jan 11.
2
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain.
Cancer Biol Ther. 2020;21(3):223-230. doi: 10.1080/15384047.2019.1683324. Epub 2019 Nov 10.
3
Botryllamides: natural product inhibitors of ABCG2.
ACS Chem Biol. 2009 Aug 21;4(8):637-47. doi: 10.1021/cb900134c.
4
Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity.
Drug Des Devel Ther. 2015 Jul 3;9:3481-95. doi: 10.2147/DDDT.S84982. eCollection 2015.
6
AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Cancer Lett. 2014 Aug 1;350(1-2):61-8. doi: 10.1016/j.canlet.2014.04.008. Epub 2014 Apr 18.
7
Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance.
Int J Biochem Cell Biol. 2014 Jun;51:111-9. doi: 10.1016/j.biocel.2014.03.026. Epub 2014 Apr 12.

引用本文的文献

1
Creating and screening natural product libraries.
Nat Prod Rep. 2020 Jul 1;37(7):893-918. doi: 10.1039/c9np00068b. Epub 2020 Mar 18.
2
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain.
Cancer Biol Ther. 2020;21(3):223-230. doi: 10.1080/15384047.2019.1683324. Epub 2019 Nov 10.
3
Ascidian Toxins with Potential for Drug Development.
Mar Drugs. 2018 May 13;16(5):162. doi: 10.3390/md16050162.
4
Marine Natural Products as Models to Circumvent Multidrug Resistance.
Molecules. 2016 Jul 8;21(7):892. doi: 10.3390/molecules21070892.
5
Marine natural products as breast cancer resistance protein inhibitors.
Mar Drugs. 2015 Apr 3;13(4):2010-29. doi: 10.3390/md13042010.
6
Bioactive dehydrotyrosyl and dehydrodopyl compounds of marine origin.
Mar Drugs. 2010 Dec 6;8(12):2906-35. doi: 10.3390/md8122906.

本文引用的文献

1
Botryllamides: natural product inhibitors of ABCG2.
ACS Chem Biol. 2009 Aug 21;4(8):637-47. doi: 10.1021/cb900134c.
3
ABCG2: determining its relevance in clinical drug resistance.
Cancer Metastasis Rev. 2007 Mar;26(1):39-57. doi: 10.1007/s10555-007-9042-6.
5
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
J Biomol Screen. 2006 Mar;11(2):176-83. doi: 10.1177/1087057105284576. Epub 2006 Feb 20.
6
Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.
Annu Rev Genomics Hum Genet. 2005;6:123-42. doi: 10.1146/annurev.genom.6.080604.162122.
7
Total synthesis of dictyodendrin B.
J Am Chem Soc. 2005 Aug 24;127(33):11620-1. doi: 10.1021/ja0541175.
8
ABCG2 (BCRP) expression in normal and malignant hematopoietic cells.
Hematol Oncol. 2003 Sep;21(3):115-30. doi: 10.1002/hon.714.
9
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15649-54. doi: 10.1073/pnas.202607599. Epub 2002 Nov 12.
10
Total syntheses of (+/-)-anchinopeptolide D and (+/-)-cycloanchinopeptolide D.
J Org Chem. 2000 Feb 11;65(3):793-800. doi: 10.1021/jo991454l.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验